DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free
about
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel diseaseStrategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel diseaseMicroRNA in inflammatory bowel disease: Translational research and clinical implicationBiomarkers for colitis-associated colorectal cancerProteins That Underlie Neoplastic Progression of Ulcerative Colitis.Array-based comparative genomic hybridization in ulcerative colitis neoplasia: single non-dysplastic biopsies distinguish progressors from non-progressors.Field cancerization in the intestinal epithelium of patients with Crohn's ileocolitis.Passenger mutations as a marker of clonal cell lineages in emerging neoplasiaThe inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curveUp-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancerInflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitisCarcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability.Using optical markers of nondysplastic rectal epithelial cells to identify patients with ulcerative colitis-associated neoplasia.Management of extraintestinal manifestations and other complications of inflammatory bowel disease.Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage.Inflammatory bowel disease: the problems of dysplasia and surveillance.Genomic biomarkers to improve ulcerative colitis neoplasia surveillance.Colon cancer stem cells: implications for prevention and therapy.Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.Pathogenesis and biomarkers of carcinogenesis in ulcerative colitis.Field cancerization in the GI tract.Keratins in colorectal epithelial function and disease.Pre-tumour clones, periodic selection and clonal interference in the origin and progression of gastrointestinal cancer: potential for biomarker development.Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.Clonal evolution of colorectal cancer in IBD.Correlation of CCL20 expression in rectal mucosa with the development of ulcerative colitis-associated neoplasia.Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia/cancer.The present status and problems with diagnosis and management of dysplasia/colitic cancer in ulcerative colitis.Colorectal Cancer Blood-Based Biomarkers.miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.The initiation of colon cancer in a chronic inflammatory setting.Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.Genetics of inflammatory bowel disease and associated cancers
P2860
Q24246110-D1311670-2C5B-47C8-965A-392CFD8E1866Q24247198-A9104E06-83BF-45A9-B1B0-FCA3CC54D326Q26775937-226EDEB0-0297-41C6-A645-F81467EC6662Q28076165-BA2004EB-58DC-43E3-882F-3D39AF86DC37Q33604387-B2146363-9E81-4BD9-81B4-216FDC1BEBC3Q34100636-66DE8342-13D3-425A-80E3-92DF32F0718FQ34104498-9B2ABCB5-2DC7-4BAF-A511-29FF1C9288A1Q34361056-B21E618E-3AE9-483C-84C1-5254B617D26EQ34557148-2D59797B-89AD-488B-9B57-D956481CF354Q34647535-D0C09219-ADAF-4F68-89E0-826F5A256B9DQ34662592-EBEA29C1-5236-49E7-ACD3-D1C7BBC2C739Q34984467-C718416C-910F-4AAA-9032-CC7CF5C99F5CQ35115850-D501DAC2-199E-4F5F-829A-4ED6C9EF2DE9Q35939996-0A99067A-DBB0-4899-8C55-73BAE1705FB0Q36953271-746A1BF2-3B93-49FB-B406-F7F93E5006E7Q37024833-4B78CF04-ECE2-4183-AAE2-FA5BA12C5782Q37061118-5A1B40B3-75E1-4450-83A0-D10F41BEB680Q37301938-AFB90672-D17E-4521-B1E9-F4A4A26AF841Q37331686-7E6B7884-4731-40D9-A9E0-69E1675504A9Q37885729-54F5DA1C-576E-409D-BF71-E139DFA04848Q37913358-755815BA-749C-46AB-9708-4D470A88773CQ38043040-385F2E9B-8692-42ED-AB40-88EA1F52C3A4Q38071593-04EDDA42-7563-41C9-A968-ABBFC4CFF1EBQ38404877-4C3A3AC3-AA85-4563-A193-AEA9371532B2Q38973304-02CD3AA2-AFA9-4629-950A-0B2CAB98C5E1Q41912959-9B813BD8-C026-4F53-9068-E7B1FAD80858Q42252707-91817536-7D80-45FA-BA8E-AB633F471DADQ44748462-7C45F27A-5467-47A1-A295-1A98347543DBQ46578913-04F5F38B-A525-4755-B09C-0C9559E8DDE7Q50595113-EEECBDDF-699E-440A-9F57-048507D69059Q53358542-3E94440B-68A4-4082-8A11-46C4F3362EFEQ55411157-17D8664C-B10C-4333-8A9E-FC7F818452CBQ58104567-7AB569FC-107D-4741-B749-7598CF8C48ED
P2860
DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
DNA fingerprinting abnormaliti ...... who are dysplasia/cancer-free
@ast
DNA fingerprinting abnormaliti ...... who are dysplasia/cancer-free
@en
type
label
DNA fingerprinting abnormaliti ...... who are dysplasia/cancer-free
@ast
DNA fingerprinting abnormaliti ...... who are dysplasia/cancer-free
@en
prefLabel
DNA fingerprinting abnormaliti ...... who are dysplasia/cancer-free
@ast
DNA fingerprinting abnormaliti ...... who are dysplasia/cancer-free
@en
P2093
P2860
P1476
DNA fingerprinting abnormaliti ...... who are dysplasia/cancer-free
@en
P2093
David A Crispin
Kent M Koprowicz
Mary J Emond
Mary P Bronner
Peter S Rabinovitch
Teresa A Brentnall
P2860
P304
P356
10.1016/S0002-9440(10)63860-6
P407
P577
2003-02-01T00:00:00Z